Point72 Asset Management
PCVX icon

Point72 Asset Management’s Vaxcyte PCVX Stock Holding History

Point72 Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-620,401
Closed -$36.1M – 4446
2026
Q1 		$36.1M Buy
620,401
+458,787
+284% +$24.9M 0.05% 518
2025
Q4 		$7.46M Sell
161,614
-535,229
-77% -$23.9M 0.01% 1544
2025
Q3 		$25.1M Buy
+696,843
New +$23.1M 0.04% 478
2025
Q2 		– Sell
-245,317
Closed -$9.26M – 2500
2025
Q1 		$9.26M Sell
245,317
-5,738
-2% -$459K 0.02% 707
2024
Q4 		$20.6M Sell
251,055
-108,741
-30% -$10.8M 0.05% 438
2024
Q3 		$41.1M Buy
+359,796
New +$32.4M 0.1% 229
2024
Q1 		– Sell
-30,155
Closed -$1.89M – 2519
2023
Q4 		$1.89M Sell
30,155
-621,030
-95% -$32.3M ﹤0.01% 1227
2023
Q3 		$33.2M Buy
651,185
+452,789
+228% +$22.3M 0.1% 271
2023
Q2 		$9.91M Sell
198,396
-302,704
-60% -$14.3M 0.03% 587
2023
Q1 		$18.8M Buy
501,100
+198,500
+66% +$8.42M 0.06% 368
2022
Q4 		$14.5M Sell
302,600
-120,200
-28% -$4.72M 0.05% 429
2022
Q3 		$10.1M Buy
+422,800
New +$10.7M 0.04% 500

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Point72 Asset Management's PCVX Position: Q2 2026 in Review

Point72 Asset Management sold out of Vaxcyte (PCVX) in Q2 2026, closing a stake of 620,401 shares — an estimated $36.1M sold.

Point72 Asset Management first reported a position in PCVX in Q3 2022 and held it in 12 quarters. The position peaked at $41.1M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Point72 Asset Management reported no remaining Vaxcyte position as of Q2 2026 after selling out during the quarter.
  • Point72 Asset Management sold 620,401 Vaxcyte shares in Q2 2026, an estimated $36.1M.
  • Point72 Asset Management first reported a position in Vaxcyte in Q3 2022 and held it in 12 quarters.
  • Point72 Asset Management's Vaxcyte position peaked at $41.1M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.